Exact Sciences (EXAS) Receivables - Net (2014 - 2025)

Exact Sciences (EXAS) has 12 years of Receivables - Net data on file, last reported at $298.7 million in Q4 2025.

• Receivables - Net for Q4 2025 came in at $298.7 million, up 19.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $298.7 million (up 19.96% YoY), and the FY2025 annual result was $298.7 million, up 970.44% from the prior year.
• Receivables - Net declined to $298.7 million in Q4 2025 per EXAS's latest filing, from $306.1 million in the prior quarter.
• Over five years, Receivables - Net peaked at $353.3 million in Q2 2025 and troughed at $28.0 million in Q1 2025.
• A 5-year average of $222.9 million and a median of $221.6 million in 2021 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2021 and 2025: Receivables - Net jumped 82.89% in 2021, then tumbled 88.36% in 2025.
• A 5-year view of Receivables - Net shows it stood at $216.6 million in 2021, then retreated by 27.05% to $158.0 million in 2022, then advanced by 28.84% to $203.6 million in 2023, then grew by 22.27% to $249.0 million in 2024, then climbed by 19.96% to $298.7 million in 2025.
• Business Quant data shows EXAS's Receivables - Net at $298.7 million in Q4 2025, $306.1 million in Q3 2025, and $353.3 million in Q2 2025.